Jump to main content
Jump to site search

Issue 8, 2017
Previous Article Next Article

Stereoisomers of oseltamivir – synthesis, in silico prediction and biological evaluation

Author affiliations

Abstract

Oseltamivir is an important antiviral drug, which possess three chirality centers in its structure. From eight possible stereoisomers, only two have been synthesized and evaluated so far. We describe herein the stereoselective synthesis, computational activity prediction and biological testing of another three diastereoisomers of oseltamivir. These isomers have been synthesized using stereoselective organocatalytic Michael addition, cyclization and reduction. Their binding to viral neuraminidase N1 of influenza A virus was evaluated by quantum-chemical calculations and their anti-influenza activities were tested by an in vitro virus-inhibition assay. All three isomers displayed antiviral activity lower than that of oseltamivir, however, one of the stereoisomers, (3S,4R,5S)-isomer, of oseltamivir showed in vitro potency towards the Tamiflu-sensitive influenza viral strain A/Perth/265/2009(H5N1) comparable to Tamiflu.

Graphical abstract: Stereoisomers of oseltamivir – synthesis, in silico prediction and biological evaluation

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Dec 2016, accepted on 26 Jan 2017 and first published on 26 Jan 2017


Article type: Paper
DOI: 10.1039/C6OB02673G
Citation: Org. Biomol. Chem., 2017,15, 1828-1841
  •   Request permissions

    Stereoisomers of oseltamivir – synthesis, in silico prediction and biological evaluation

    V. Hajzer, R. Fišera, A. Latika, J. Durmis, J. Kollár, V. Frecer, Z. Tučeková, S. Miertuš, F. Kostolanský, E. Varečková and R. Šebesta, Org. Biomol. Chem., 2017, 15, 1828
    DOI: 10.1039/C6OB02673G

Search articles by author

Spotlight

Advertisements